218 related articles for article (PubMed ID: 24605934)
1. Exendin-4 shows no effects on the prostatic index in high-fat-diet-fed rat with benign prostatic hyperplasia by improving insulin resistance.
Zheng JX; Xiao YC; Hu YR; Hao M; Kuang HY
Andrologia; 2015 Mar; 47(2):236-42. PubMed ID: 24605934
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
[TBL] [Abstract][Full Text] [Related]
3. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
Vikram A; Jena GB; Ramarao P
Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
[TBL] [Abstract][Full Text] [Related]
4. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
5. High-fat diet obesity associated with insulin resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate.
Ribeiro DL; Pinto ME; Rafacho A; Bosqueiro JR; Maeda SY; Anselmo-Franci JA; Taboga SR; Góes RM
J Androl; 2012; 33(5):854-65. PubMed ID: 22441765
[TBL] [Abstract][Full Text] [Related]
6. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
7. [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
Zhao DX; Ma L; Shen ZA; Li DW; Shang YR; Yin K; Cheng WF; Wang X; Liu ZX
Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):752-758. PubMed ID: 28043300
[No Abstract] [Full Text] [Related]
8. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model.
Kim SK; Seok H; Park HJ; Jeon HS; Kang SW; Lee BC; Yi J; Song SY; Lee SH; Kim YO; Chung JH
BMC Complement Altern Med; 2015 Oct; 15():380. PubMed ID: 26490686
[TBL] [Abstract][Full Text] [Related]
10. Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model.
Jang H; Ha US; Kim SJ; Yoon BI; Han DS; Yuk SM; Kim SW
J Agric Food Chem; 2010 Dec; 58(24):12686-91. PubMed ID: 21121678
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.
Vikram A; Jena G; Ramarao P
Br J Pharmacol; 2010 Dec; 161(8):1708-21. PubMed ID: 20726985
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia.
Bisson JF; Hidalgo S; Simons R; Verbruggen M
J Med Food; 2014 Jun; 17(6):650-6. PubMed ID: 24460407
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
19. High fat-induced obesity associated with insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate.
Ribeiro DL; Pinto ME; Maeda SY; Taboga SR; Góes RM
Cell Tissue Res; 2012 Aug; 349(2):577-88. PubMed ID: 22661309
[TBL] [Abstract][Full Text] [Related]
20. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
Zheng H; Xu W; Lin J; Peng J; Hong Z
Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
